Friday | 21 November, 2008
Australian Biotechnology News
CathRx sells first product to Europe
Diagnostic modular heart catheters first of several planned for European market
Dylan Bushell-Embling 17/09/2008 14:00:00

CathRx [ASX: CXD] has secured the first sales of its diagnostic modular heart catheters to its UK distributor, in the company's first ever sale to Europe.

Cardiac catheters are minimally invasive tools widely used by specialist cardiologists to help diagnose and treat different types of cardiac arrhythmias.

The global market for cardiac catheters is predicted to be around $1.25 billion, with the European market alone worth $333.2 million.

CathRx plans to offer a progressively-expanding 'toolbox' of heart surgery tools to the European market in the next three quarters.

Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links